E-DRUG: PhD programme for professionals at Utrecht University (NL)
-----------------------------------------------------------------------------------------------------
Dear colleagues,
The Utrecht Centre for Pharmaceutical Policy and Regulation (scientific director: prof.dr. H.G.M. Leufkens) offers an international high quality PhD-programme for professionals with several years of relevant work experience. The unique format of the programme combines academic research and public health practice requiring candidates to use their work experience, data and policy issues as input for their PhD-thesis.
The Centre intends to enrol 2-3 new students in October 2014.
Applications can be submitted before 1 June 2014.
More information can be obtained from the Centre's website:
http://www.pharmaceuticalpolicy.nl
Inquiries can be sent to Mrs. Rianne van den ham <h.a.vandenham@uu.nl>.
Research themes
The work of the Centre concentrates on the design and evaluation of pharmaceutical policies with a focus on Global Health, Drug Regulatory Science and Governance/Ethics. Work of the applicant should be in this field. Applicants with (research) experience in Drug Regulation and Governance/Ethics are especially invited to apply.
What do we offer?
· Part time multidisciplinary PhD-programme; duration of 3-5 years depending on available time and individual effort; the final PhD thesis should consist of an appropriate mix of quantitative and qualitative research methods resulting in 6-7 papers suitable for publication;
· Supervision by acknowledged researchers in the field of drug regulation, pharmacoepidemiology and pharmaceutical policy analysis;
· A stimulating research environment including regular courses and other meetings (eg. Pharmaceutical Policy Analysis (PPA) summer course, WHO CC Winter meeting)
· Remote access to library and other facilities of Utrecht University;
· No financial support for travelling and courses can be offered.
· A fee will be charged for the PhD supervisory activities (5000 euros for total period of time; waivers may be provided), which may be refundable after completion of the PhD thesis.
Features of a typical PhD thesis in this program
· 6-7 original papers, at least 3 should be published / accepted in peer reviewed journals;
· Good mixture of different methods, both qualitative and quantitative research;
· High-level introduction and discussion chapter;
· An example of a typical and more detailed workplan can be found on the website.
Best wishes,
Aukje Mantel
Aukje Mantel-Teeuwisse, PhD
Managing director WHO Collaborating Centre for Pharmaceutical Policy and Regulation (www.pharmaceuticalpolicy.nl<http://www.pharmaceuticalpolicy.nl/>\)
Utrecht Institute for Pharmaceutical Sciences | Division Pharmacoepidemiology & Clinical Pharmacology |
PO Box 80 082 | 3508 TB Utrecht | The Netherlands | Tel: +31 6 22736017 or +31 30 253 7324 (secretariat)
Visiting address:
David de Wied building | Universiteitsweg 99 | 3584 CG Utrecht | the Netherlands
"Mantel-Teeuwisse, A.K. (Aukje)" <A.K.Mantel@uu.nl>